BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1202605)

  • 1. Rheumatoid synovitis: complement and immune complexes.
    Schur PH; Britton MC; Franco AE; Corson JM; Sosman JL; Ruddy S
    Rheumatology; 1975; 6():34-42. PubMed ID: 1202605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
    Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
    Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes and complement in rheumatoid arthritis.
    Duquesnoy B
    Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immune complexes and complement components in arterial and venous blood of patients with rheumatoid arthritis.
    Steven MM; Westedt ML; Daha MR; de Vries E; Cats A
    J Rheumatol; 1986 Feb; 13(1):74-8. PubMed ID: 3701744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rheumatoid synovitis (problems of immunomorphology and immunopathogenesis)].
    Strukov AI; Makarova OV
    Arkh Patol; 1982; 44(6):3-13. PubMed ID: 6289782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 inactivator-C1s complexes in inflammatory joint disease.
    Inman RD; Harpel PC
    Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C4 component of complement, rheumatoid factors and circulating immunocomplexes in rheumatoid-arthritis and reactive synovitides of local origin; serum synovial fluid].
    Hrncír Z; Tichý M; Salavec M; Vavrina J
    Cas Lek Cesk; 1978 Dec; 117(49):1526-9. PubMed ID: 737699
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
    Emmrich J; Geiler G
    Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes and complement in rheumatoid arthritis.
    Lambert PH; Casali P; Nydegger U
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
    Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: an immune complex disease? A review of the reaction of antigen with antibody to form immune complexes and the mechanisms by which they mediate tissue injury.
    Hester RB; Bennett JC
    Geriatrics; 1973 Jun; 28(6):84-91. PubMed ID: 4126064
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of rheumatoid arthritis.
    Harris ED
    Clin Orthop Relat Res; 1984; (182):14-23. PubMed ID: 6420100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.